Related Experiment Video
Updated: Sep 28, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Time to Move on: HLA Matching Should Be Reconsidered in Modern Deceased Donor Kidney Allocation
Madelyn E Gramlick1, Paul Trevillian2,3, Kerrin L Palazzi4
1Surgical Services, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.
Kidney transplants with Human Leukocyte Antigen (HLA) matching show improved graft and patient survival, but this benefit may be linked to reduced dialysis time. This matching process also appears to contribute to racial inequities in transplantation.
Area of Science:
- Nephrology
- Transplantation immunology
- Public health
Background:
- Human Leukocyte Antigen (HLA) matching is a key factor in deceased donor kidney allocation, aiming to improve transplant success.
- However, HLA matching policies can inadvertently create racial inequities, prompting consideration of non-allogenic factors like recipient age.
Purpose of the Study:
- To evaluate long-term graft and patient outcomes in deceased donor kidney transplantation based on HLA-matched versus non-matched allocation cohorts.
- To investigate the influence of reduced dialysis time on the observed benefits of HLA matching.
Main Methods:
- Analysis of 7440 adult deceased donor kidney transplants from the Australia and New Zealand Dialysis and Transplant Registry (2000-2018).
- Classification of transplants as HLA matched or nonmatched using the OrganMatch score and local allocation algorithms.
- Statistical analysis included linear mixed modeling for graft function, logistic/binomial regression for rejection, and Kaplan-Meier/Cox regression for graft failure and survival.
Main Results:
- Forty percent of transplants were HLA matched, showing significantly higher mean glomerular filtration rates.
- HLA-matched transplants demonstrated longer graft survival (15.9 vs. 12.7 years) and improved recipient survival (HR 0.83).
- Matched recipients spent less time on dialysis (28.1 vs. 44.8 months), a factor contributing to better graft and survival outcomes; Caucasian recipients were more likely to receive matched transplants.
Conclusions:
- While HLA-matched kidney transplants offer benefits in graft and recipient outcomes, some advantages appear linked to reduced dialysis duration.
- The advantages of HLA matching for some recipients came at the cost of longer dialysis times for non-matched recipients, disproportionately affecting minority racial groups.
- The study highlights the complex interplay between HLA matching, dialysis duration, and potential racial disparities in kidney allocation.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant III: Nursing Management

